Condition: Hyperuricemia or Gout · Hypertension · Sponsor: Saga University
The effect of dotinurad on CAVI (cardio-ankle vascular index) will be compared with that of febuxostat in patients with hyperuricemia complicated by hypertension.
This description comes directly from the study's public registry record.
Koichi Koichi, Pr.,Dr. · +81-952-28-8100 · next-diana@clin-med.org
Always discuss trial participation with your own doctor first.
| Saga University | Saga, Saga-ken, Japan | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06834230